Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A clinically relevant SCID-hu in vivo model of human multiple myeloma.
Tassone P, Neri P, Carrasco DR, Burger R, Goldmacher VS, Fram R, Munshi V, Shammas MA, Catley L, Jacob GS, Venuta S, Anderson KC, Munshi NC. Tassone P, et al. Among authors: venuta s. Blood. 2005 Jul 15;106(2):713-6. doi: 10.1182/blood-2005-01-0373. Epub 2005 Apr 7. Blood. 2005. PMID: 15817674 Free PMC article.
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
Tassone P, Neri P, Kutok JL, Tournilhac O, Santos DD, Hatjiharissi E, Munshi V, Venuta S, Anderson KC, Treon SP, Munshi NC. Tassone P, et al. Among authors: venuta s. Blood. 2005 Aug 15;106(4):1341-5. doi: 10.1182/blood-2004-11-4477. Epub 2005 May 10. Blood. 2005. PMID: 15886318 Free PMC article.
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P, Neri P, Burger R, Savino R, Shammas M, Catley L, Podar K, Chauhan D, Masciari S, Gozzini A, Tagliaferri P, Venuta S, Munshi NC, Anderson KC. Tassone P, et al. Among authors: venuta s. Clin Cancer Res. 2005 Jun 1;11(11):4251-8. doi: 10.1158/1078-0432.CCR-04-2611. Clin Cancer Res. 2005. PMID: 15930364
Neutralizing B-cell activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma model.
Neri P, Kumar S, Fulciniti MT, Vallet S, Chhetri S, Mukherjee S, Tai Y, Chauhan D, Tassone P, Venuta S, Munshi NC, Hideshima T, Anderson KC, Raje N. Neri P, et al. Among authors: venuta s. Clin Cancer Res. 2007 Oct 1;13(19):5903-9. doi: 10.1158/1078-0432.CCR-07-0753. Clin Cancer Res. 2007. PMID: 17908986
Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells.
Tassone P, Goldmacher VS, Neri P, Gozzini A, Shammas MA, Whiteman KR, Hylander-Gans LL, Carrasco DR, Hideshima T, Shringarpure R, Shi J, Allam CK, Wijdenes J, Venuta S, Munshi NC, Anderson KC. Tassone P, et al. Among authors: venuta s. Blood. 2004 Dec 1;104(12):3688-96. doi: 10.1182/blood-2004-03-0963. Epub 2004 Aug 3. Blood. 2004. PMID: 15292058 Free article.
Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.
Neri P, Tassone P, Shammas M, Yasui H, Schipani E, Batchu RB, Blotta S, Prabhala R, Catley L, Hamasaki M, Hideshima T, Chauhan D, Jacob GS, Picker D, Venuta S, Anderson KC, Munshi NC. Neri P, et al. Among authors: venuta s. Leukemia. 2007 Dec;21(12):2519-26. doi: 10.1038/sj.leu.2404912. Epub 2007 Sep 20. Leukemia. 2007. PMID: 17882285
143 results